Citation Tools

Download PDFPDF

2SPD-009 Cost minimisation study of the biological treatment of inflammatory bowel disease: ustekinumab versus vedolizumab
Free

Download to a citation manager

Cite this article as:
Cantarelli L, Gutierrez Nicolas F, Del Rosario Garcia B, et al
2SPD-009 Cost minimisation study of the biological treatment of inflammatory bowel disease: ustekinumab versus vedolizumab